Chief Executive, Henny Braund
Henny Braund became Chief Executive of Anthony Nolan in January 2009. Henny works with staff at all levels, Trustees and supporters, as well as external stakeholders, such as government departments. She sees it as her role to deliver our vision, champion our cause, and inspire people to help our lifesaving work.
Previously Resources Director at Shelter, the housing charity, Henny draws on 20 years experience in the voluntary sector. She is a Trustee for the Small Charities Coalition, and has been Chair for Aids and Housing (Health and Housing). She has also been a Trustee for Thamesreach and Shelter Trading.
Scientific Director, Professor J Alejandro Madrigal, MD PhD FRCP FRCPath DSc
Professor Madrigal joined Anthony Nolan in 1993. He created the Anthony Nolan Research Institute, recognised as one of the leading stem cell research institutes worldwide.
A key figure in haematology, Alejandro holds the Chair of Haematology at The Royal Free Hospital and is President of the European Group for Blood and Marrow Transplantation (EBMT). He has received many prestigious awards for his work and published over 200 papers in peer-reviewed journals (with more than 3,000 citations).
Alejandro has been Chair of AlloStem, the largest EU-funded project for immunotherapy, for four years. His main objectives are to improve the outcomes of stem cell transplants and to find new tools for cell therapy.
Head of Register Development, Ann O'Leary
Ann O’Leary is Head of Register Development at Anthony Nolan and is responsible for ensuring the optimum size and composition of Anthony Nolan's Register of potential bone marrow donors. Ann has been working in the area of altruistic donor recruitment for 8 years, having spent 4 years as Specialist Donor Recruiter with the Irish Blood Transfusion Service before moving to Anthony Nolan in 2010.
Ann is available to discuss issues around recruitment to the bone marrow register, including patient appeals, recruitment levels and policies, donor education and retention of donors on the register.
Engagement Director, Richard Davidson
Richard Davidson has been Director of Communications and Marketing at Anthony Nolan since July 2010, overseeing significant rebranding and policy campaigns that have helped refocus Anthony Nolan’s image and objectives for the 21st century.
Previously a Director of MHP Health Mandate, Richard is perhaps best known for his role as Cancer Research UK's Director of Policy and Public Affairs where he oversaw the organisation's policy formulation, external affairs, public campaigning and the tobacco control work that eventually led to the UK smoking ban.
As Communications and Marketing chief, Richard can speak about focused issues such as brand campaigns and register development, as well as give background detail around the organisation’s broader and longer-term goals.
Assistant Director of Engagement (Awareness and Influencing) , Katie Begg
Katie Begg joined Anthony Nolan in November 2012 as Head of Policy and Public Affairs. She leads our government and parliamentary relations activities, as well as stakeholder engagement within our sector. Katie takes responsibility for developing a clear public policy agenda for Anthony Nolan, driven by our core ambitions of securing a donor for every person who needs one, and improving the lives of blood cancer patients.
Before joining us, Katie held a number of positions within the public affairs and communications arena, including as Associate Director of a boutique political communications agency, and as European Public Affairs Manager at a FTSE 250 corporation. During this time she managed lobbying and policy campaigns for a range of organisations in the UK and Europe.
Laboratory Director and Senior Research Scientist, Dr Katy Latham
Dr Katy Latham is our Laboratory Director and Senior Research Scientist. She is responsible for the charity’s histocompatibility and immunogenetics services.
Katy started her career as a research and development scientist in the biotech industry, later gaining her PhD in Transplantation Genetics at the University of Manchester. For her thesis, Katy investigated the role of genotyping in predicting renal graft survival, working in collaboration with the NHS and industry. Katy has many years’ experience in her field, largely earned as a Clinical Scientist with the Central Manchester NHS Foundation Trust and by gaining the FRCPath.
At Anthony Nolan, Katy is working to push the boundaries of HLA testing for the charity’s register, by implementing new technologies and achieving high throughput of new donors added to the register. Katy also leads on a collaboration project with NHS Blood & Transplant, making her role key to improving the provision of UK bone marrow donors for blood cancer patients both in the UK and worldwide.
Director of Bioinformatics, Deputy Director of Research & Co-Director of Histocompatibility Laboratories, Prof Steven Marsh, BSc, PhD, ARCS
Prof Marsh is Deputy Director of Research and Head of Immunogenetics at the Anthony Nolan Research Institute and Co-Director of our Histocompatibility Laboratory.
He is also Professor of Immunogenetics at University College London and Chairman of the World Health Organization (WHO) Nomenclature Committee for Factors of the HLA System, and the WHO/IUIS Nomenclature Committee for Killer-cell Immunoglobulin-like Receptors (KIR). He is a former President of the European Federation for Immunogenetics (EFI) and President of the International HLA and Immunogenetics Workshop.
The aim of his research group is to improve the outcome of haematopoietic stem cell transplantation by understanding genetic differences between patients and donors including HLA, KIR and their roles in matching achieved by both bioinformatics and laboratory-based projects. He initiated the IMGT/HLA and IPD-KIR Databases, which are the worldwide resource for HLA and KIR sequences.